Latest News about Analyst Color
Recent news which mentions Analyst Color
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
November 11, 2024
From Benzinga
Cboe Upgraded To Buy: Deutsche Bank Sees Strong Revenue Growth And Margin Gains Through 2025
November 11, 2024
From Benzinga
Trump Trade Sparks Biggest Financial Stock Inflows In 2 Years
November 11, 2024
From Benzinga
From Benzinga
Cisco Gains Ahead Of Q1 Earnings As JPMorgan Projects Networking Market Recovery In 2025
November 11, 2024
From Benzinga
Solar, Renewables Stocks Crash After Trump Win: Should You Buy Now At Cheap Valuations?
November 11, 2024
From Benzinga
Bitcoin's Rally to $82K Post Trump's Election Win Not Enough To Flip Over Long-Term Critic Peter Schiff: No Fundamentals, Just 'Mania'
November 11, 2024
From Benzinga
From Benzinga
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
November 11, 2024
From Benzinga
Tesla Remains Core For Gary Black Despite Price Cuts, Earnings Drop — Nvidia, Google, Eli Lilly Among Top Performers In Tech Bull's Portfolio
November 10, 2024
From Benzinga
From Benzinga
SolarEdge Is A 'Show-Me Story' After Disappointing Q3: Analyst
November 08, 2024
From Benzinga
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
November 08, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside
November 08, 2024
From Benzinga
Lucid's Delivery Gains, New SUV Can't Shake Profit Concerns
November 08, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.